GJE has been listed as a recommended firm in the JUVE Patent UK Rankings 2023
Posted:
GJE has been listed as a recommended firm in the JUVE Patent UK Rankings 2023. The firm also received a new recommendation in the pharma and biotechnology field. Read more here.
Capital planning in healthcare is not merely an administrative obligation—it is a strategic discipline that shapes clinical capabilities, operational resilience and financial health.
Recognising and addressing common planning mistakes is essential to sustaining high-quality, efficient care in an increasingly complex…
The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of…
Attendees
Sponsors and Exhibitors
Contact us